Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1183/13993003.02384-2020 http://scihub22266oqcxt.onion/10.1183/13993003.02384-2020 33154030!7651836!33154030     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+Respir+J 2021 ; 57 (3): ä Nephropedia Template TP {{tp|p=33154030|t=2021. Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure |pdf=|usr=}}{{33154030}} gab.com Text Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure JO: Eur Respir J http://www.kidney.de/pget.php?&tw=1&pmid=33154030 #FOAvip The plasma of COVID-19 patients induces pulmonary microvascular barrier failure, which increases with disease severity. Here, a screening platform to test for plasma mediators and the therapeutic potential of barrier stabilising compounds is reported. https://bit.ly/3k4C0tB Twit Text FOAVip Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure ????Eur Respir J http://www.kidney.de/pget.php?&tw=1&pmid=33154030 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33154030 #FOAvip English Wikipedia <ref>{{Cite pmid|33154030}}</ref> Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure #MMPMID33154030 Michalick L; Weidenfeld S; Grimmer B; Fatykhova D; Solymosi PD; Behrens F; Dohmen M; Brack MC; Schulz S; Thomasch E; Simmons S; Muller-Redetzky H; Suttorp N; Kurth F; Neudecker J; Toennies M; Bauer TT; Eggeling S; Corman VM; Hocke AC; Witzenrath M; Hippenstiel S; Kuebler WM Eur Respir J 2021[Mar]; 57 (3): ä PMID33154030show ga The plasma of COVID-19 patients induces pulmonary microvascular barrier failure, which increases with disease severity. Here, a screening platform to test for plasma mediators and the therapeutic potential of barrier stabilising compounds is reported. https://bit.ly/3k4C0tB |*Capillary Permeability[MESH] |*Electric Impedance[MESH] |*Plasma[MESH] |Actins/metabolism[MESH] |Antigens, CD/metabolism[MESH] |COVID-19/blood/*metabolism[MESH] |Cadherins/metabolism[MESH] |Case-Control Studies[MESH] |Endothelial Cells/*metabolism[MESH] |Endothelium/*metabolism[MESH] |Hospitalization[MESH] |Humans[MESH] |Lung/metabolism[MESH] |Microvessels/cytology[MESH] |Occludin/metabolism[MESH] |SARS-CoV-2[MESH]Plasma mediators in patients with severe COVID-19 cause lung endotheli(epmc).pdf DeepDyve Pubget Overpricing